ZyVersa Therapeutics Balance Sheet Health
Financial Health criteria checks 2/6
ZyVersa Therapeutics has a total shareholder equity of $7.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $19.4M and $12.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$122.92k |
| Equity | US$7.03m |
| Total liabilities | US$12.40m |
| Total assets | US$19.42m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ZVSA's short term assets ($390.4K) do not cover its short term liabilities ($11.5M).
Long Term Liabilities: ZVSA's short term assets ($390.4K) do not cover its long term liabilities ($854.6K).
Debt to Equity History and Analysis
Debt Level: ZVSA is debt free.
Reducing Debt: ZVSA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ZVSA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ZVSA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 29.6% each year